Today’s value based reimbursement programs require hospitals and health systems to shorten the length of time patients are hospitalized, reduce readmissions and improve quality of care. When post-acute infusion therapy is required, these challenges can be heightened, but are readily achievable for individuals who are relatively healthy, stable, and financially secure.

However, the risk of poor outcomes increases significantly for those who: are sicker and have comorbidities; have limited caregiver support; lack transportation options; or have Medicare without a Medigap plan, a deductible commercial plan or are uninsured or underinsured. 

Click the link below to read the full article from Managed Health Executive. 

Managed-Healthcare-Executive-Innovative-Solutions-Help-Patients

Share Post